In recent years, there has been a significant rise in the interest and acceptance of psilocybin mushrooms across Canada.

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.

The vaccine delivery technology landscape is highly competitive and has been evolving rapidly over the past decade. The technology research environment involves numerous startup companies, major ...